# US 2024/0197593 A1 · Cleansing composition for female intimate hygiene

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197593 A1
- Document ID: US20240197593A1
- Status: Published application
- Kind: A1
- Application number: 18/286,492
- Filed: 2022-04-14
- Published: 2024-06-20
- Earliest claimed: 2021-04-16
- Assignees: Conopco, Inc., d/b/a UNILEVER
- Applicants: Conopco, Inc., d/b/a UNILEVER
- Inventors: Samarth BHARADWAJ; Sandeep GUPTA; Renu KAPOOR; Rupak MITRA; Rohini Sukumaran NAIR; Lin YANG; Ashish Shrikant YEKHE
- Web page: https://patentgrep.com/patent/US20240197593A1

## CPC

- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/60: Sugars; Derivatives thereof
- A61K 8/604: {Alkylpolyglycosides; Derivatives thereof, e.g. esters}
- A61K 8/73: Polysaccharides
- A61Q 17/005: {Antimicrobial preparations}
- A61Q 19/005: {Preparations for sensitive skin}
- A61Q 19/10: Washing or bathing preparations
- A61K 2800/30: Characterized by the absence of a particular group of ingredients
- A61K 2800/48: Thickener, Thickening system
- A61K 2800/596: Mixtures of surface active compounds
- A61K 2800/74: Biological properties of particular ingredients
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Disclosed is an aqueous sulphate-free cleansing composition for female intimate hygiene, said composition comprising: a) 1 to 20 wt % of a non-soap surfactant system comprising combination two or more sulphate-free surfactants selected from glycinates, betaines, alkyl polyglucosides and amphoacetates; b) 0.05 to 4 wt % of a prebiotic capable of being broken down by Lactobacilli to lactic acid; and, c) 0.001 to 3 wt % lactic acid or a salt thereof added as a postbiotic; wherein said composition is free of live bacteria including Lactobacilli.

## Claims

### Claim 1

An aqueous sulphate-free cleansing composition for female intimate hygiene, the composition comprising:
a) 1 to 20 wt % of a non-soap surfactant system comprising a combination of at least three sulphate-free surfactants selected from glycinates, betaines, alkyl polyglucosides and amphoacetates;
b) 0.05 to 4 wt % of a prebiotic capable of being broken down by Lactobacilli to lactic acid; and,
c) 0.001 to 3 wt % lactic acid or a salt thereof added as a postbiotic;
wherein said composition is free of live bacteria including Lactobacilli.

### Claim 2 (depends on 1)

The aqueous composition according to claim 1, wherein when the non-soap surfactant system comprises glycinates, the glycinates are in the range of 0.5 to 5 wt %.

### Claim 3 (depends on 1)

The aqueous composition according to claim 1, wherein when the non-soap surfactant system comprises betaines, the betaines are in the range of 0.5 to 8 wt %.

### Claim 4 (depends on 1)

The aqueous composition according to claim 1, wherein the non-soap surfactant system comprises alkyl polyglucosides comprising ethers or mixtures of ethers of fatty alcohols.

### Claim 5 (depends on 1)

The aqueous composition according to claim 1, wherein the composition has a pH from 3.0 to 7.5.

### Claim 6 (depends on 1)

The aqueous composition according to claim 1, wherein the composition comprises a rheological additive selected from the group consisting of polyethylene glycol distearates, acylates, starch, derivatives of starch, carbohydrate gums, cationic polymer, cationic galactomannans, polyethylene glycols, waxes and polymeric thickeners.

### Claim 7 (depends on 1)

The aqueous composition according to claim 1, wherein viscosity of the composition is in a range of 2500 to 10000 cps.

### Claim 8 (depends on 1)

The aqueous composition according to claim 1, wherein the prebiotic is an oligosaccharide, fructan, sugar alcohol or a complex polysaccharide and the sugar alcohol is glycerol or lactitol.

### Claim 9 (depends on 1)

The aqueous composition according to claim 1, wherein the composition comprises a preservative which is sodium benzoate, phenoxyethanol, 4-isopropyl-3-methylphenol, sodium salicylate, a parabens, hydantoins, benzyl alcohol, benzoic acid, iodopropynyl butylcarbamate 5-chloro-2-methyl-2H-isothiazol-3-one, 2-methyl-2H-isothiazol-3-one, caprylyl glycol, phenylpropanol, o-Cymen-5-ol and decylene glycol or a mixture thereof.

### Claim 10 (depends on 1)

The aqueous composition according to claim 1, wherein the composition comprises 2 to 15 wt % humectant selected from the group consisting of propylene glycol, hexylene glycol, 1,4-dihydroxyhexane, 1,2,6-hexanetriol, sorbitol, butylene glycol, caprylyl glycol, propanediol, dipropylene glycol, triethylene glycol, glycerin, polyethylene glycol, ethoxydiglycol, polyethylene sorbitol, glyceryl caprylate/caprate, and combinations thereof.

### Claim 11 (depends on 1)

The aqueous composition according to claim 1, wherein the composition reduces a count of at least G. vaginalis inhabiting female intimate region by at least 5-log but does not reduce a count of at least L. crispatus by more than 3 log using Time-Kill as determined per ASTM E2783-11.

### Claim 12 (depends on 1)

The aqueous composition according to claim 1, wherein the prebiotic is an oligosaccharide.

### Claim 13 (depends on 1)

The aqueous composition according to claim 1 wherein the composition further comprises an antimicrobial active, antifungal active, vitamin, anti-skin atrophy active, skin repair active, skin barrier repair active non-steroidal cosmetic soothing active, skin tightening agent, anti-itch ingredient hair growth inhibitor, 5-alpha reductase inhibitor, desquamating enzyme enhancer, anti-glycation agent, topical anesthetic, or a mixture thereof.

### Claim 14 (depends on 1)

A non-therapeutic method of providing female intimate hygiene comprising the steps of contacting a female intimate region with the composition according to claim 1 for a contact time of at least 30 seconds and washing the region.
